Company Search:
Advanced Search
Sponsored Links
Neurometrix, Inc. Company Snapshot
Neurometrix, Inc. operates within the Surgical and medical instruments sector. In addition to historical fundamental analyses, the complete report available to purchase compares Neurometrix with three other companies in this sector in the United States: Sonoma Pharmaceuticals Inc (2018 sales of $16.66 million of which 100% was Drugs & Devices), Repro-Med Systems, Inc. ($17.35 million ), and Apyx Medical Corp ($16.69 million of which 78% was Advance Energy).

Sales Analysis. During the year ended December of 2018, sales at Neurometrix were $16.09 million. This is a decrease of 5.9% versus 2017, when the company's sales were $17.09 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Neurometrix, Inc.
  Stock Performance Chart for Neurometrix, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): .27
(Figures in U.S. Dollars)
1 Week -8.8%   13 Weeks -5.0%  
4 Weeks -15.8%   52 Weeks -74.6%  
Neurometrix, Inc. Key Data:
  Ticker: NURO Country: United States
  Exchanges: NAS Major Industry: Health Care Equipment & Services
    Sub Industry: Surgical & Medical Instruments
  2018 Sales 16,090,138
(Year Ending Jan 2019).
Employees: 42
  Currency: U.S. Dollars Market Cap: 2,636,183
  Fiscal Yr Ends: December Shares Outstanding: 9,781,755
  Share Type: Common Closely Held Shares: 286,022
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.